EFL008
Join host Dr. Chase Hendrickson, Vanderbilt University Medical Center, Dr. Amal Shibli-Rahhal, Director of the Metabolic Bone Disease Clinic and Fellowship Program Director at University of Iowa, and Dr. Bryan Haugen, Professor of Medicine, Chief of Endocrinology, and Director of the Thyroid Tumor Program at University of Colorado School of Medicine, as they discuss a recent Journal of the Endocrine Society (JES) article, “Long-Term Results of Treating with Ethanol Ablation 15 Adult Patients with cT1aNo Papillary Thyroid Microcarcinoma.”
Meet the Speakers
Bryan R. Haugen, MD, is Professor of Medicine and Pathology at the University of Colorado School of Medicine and a member of the University of Colorado Cancer Center. He is also Chief of the Division of Endocrinology, Metabolism & Diabetes and Director of the Thyroid Tumor Program which provides care for more than 3000 patients with thyroid cancer. He currently holds the Mary Rossick Kern and Jerome H Kern Chair in Endocrine Neoplasms Research. Dr. Haugen received his medical degree from the Mayo Medical School in 1987 and completed internship, medical residency and endocrine fellowship at the University of Colorado Health Sciences Center. Dr. Haugen was President of the American Thyroid Association (ATA) 2012-2013 and Chair of the ATA thyroid nodule and differentiated cancer guidelines task force which published the guidelines in January 2016. He has received the Paul Starr Award from the ATA for advancements in clinical thyroidology and the Sidney H Ingbar Award for his advancements in thyroid research over the past 25 years. His current clinical interests include thyroid neoplasms, advanced thyroid cancer, thyroid dysfunction and other endocrine tumors (parathyroid, adrenal, carcinoid). Dr. Haugen’s research interests include molecular studies of thyroid neoplasm diagnosis and pathophysiology as well as the study of molecular therapeutic targets. Dr. Haugen has had a great interest in caring for patients with thyroid cancer and helping to find better treatments and management strategies for these patients for more than 20 years.
Amal Shibli-Rahhal, MD, received her medical degree from the American University of Beirut and completed her post-graduate training in internal medicine and endocrinology at the University of Iowa. Dr. Shibli-Rahhal is professor and endocrinologist at the University of Iowa, where she also acts as the Assistant Dean for Student Affairs and Curriculum at the University of Iowa Carver College of Medicine and as the Endocrinology Fellowship Program Director. Previously, Dr. Shibli-Rahhal also acted a the Course Director for the College of Medicine and as Associate Chief of Staff for Education at the Iowa City VA. In addition to her role as Program Director, Dr. Shibli-Rahhal also created and serves as Director of the University of Iowa Metabolic Bone Clinic. She is also an active member of the University of Iowa's Taskforce for Diversity, Equity, and Inclusion. Resources
